Page last updated: 2024-09-05

sb 203580 and hyperforin

sb 203580 has been researched along with hyperforin in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(hyperforin)
Trials
(hyperforin)
Recent Studies (post-2010) (hyperforin)
3,48941,13739720144

Protein Interaction Comparison

ProteinTaxonomysb 203580 (IC50)hyperforin (IC50)
Prostaglandin E synthaseHomo sapiens (human)1
Cytochrome P450 3A4Homo sapiens (human)2.3
Sodium-dependent noradrenaline transporter Homo sapiens (human)2
Sodium-dependent serotonin transporterHomo sapiens (human)2
Sodium-dependent dopamine transporter Homo sapiens (human)2

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Feisst, C; Glaubitz, C; Hoffmann, M; Jakobsson, PJ; Lopez, JJ; Pawelczik, S; Pergola, C; Sorg, BL; Steinhilber, D; Werz, O1

Other Studies

1 other study(ies) available for sb 203580 and hyperforin

ArticleYear
Hyperforin induces Ca(2+)-independent arachidonic acid release in human platelets by facilitating cytosolic phospholipase A(2) activation through select phospholipid interactions.
    Biochimica et biophysica acta, 2010, Volume: 1801, Issue:4

    Topics: Arachidonic Acid; Blood Platelets; Bridged Bicyclo Compounds; Calcium; Cytosol; Enzyme Activation; Enzyme Inhibitors; Humans; Imidazoles; Magnetic Resonance Spectroscopy; p38 Mitogen-Activated Protein Kinases; Phloroglucinol; Phosphatidylcholines; Phospholipases A2; Phosphorylation; Pyridines; Terpenes

2010